Effectiveness of Abrocitinib in Cyclosporine-Resistant Atopic Dermatitis: A Real-world Experience from the Indian Subcontinent

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus and eczematous lesions. Abrocitinib, a selective Janus kinase 1 (JAK1) inhibitor, has recently been approved in India for moderate-to-severe AD in adults. This prospective real-world case series evaluated the eff...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Abhishek De, Disha Chakraborty, S. K. Shahriar Ahmed, Smriti Gupta, Sandipan Dhar, Manas Chatterjee
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wolters Kluwer Medknow Publications 2026-05-01
Цуврал:	Indian Journal of Dermatology
Нөхцлүүд:	atopic dermatitis abrocitinib cyclosporine real-world evidence selective jak inhibitor
Онлайн хандалт:	https://journals.lww.com/10.4103/ijd.ijd_516_25
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!